ArticleOncotarget2016

Assessment of bevacizumab resistance increased by expression of BCAT1 in IDH1 wild-type glioblastoma: application of DSC perfusion MR imaging.

Hye Rim Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.